Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Derivatization with fatty acids in peptide and protein drug discovery
Peter Kurtzhals, Søren Østergaard, Erica Nishimura, et al.
Nature Reviews Drug Discovery (2022) Vol. 22, Iss. 1, pp. 59-80
Closed Access | Times Cited: 75

Showing 1-25 of 75 citing articles:

Peptide–Drug Conjugates: An Emerging Direction for the Next Generation of Peptide Therapeutics
Trevor T. Dean, Juliet Jelú-Reyes, A’Lester C. Allen, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 3, pp. 1641-1661
Closed Access | Times Cited: 24
Recent advances, strategies, and future perspectives of peptide-based drugs in clinical applications
Qimeng Yang, Zhipeng Hu, Hongyu Jiang, et al.
Chinese Journal of Natural Medicines (2025) Vol. 23, Iss. 1, pp. 31-42
Closed Access | Times Cited: 3
Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines
Wen‐Jing Xiao, Wenjie Jiang, Zheng Chen, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Glucose-sensitive insulin with attenuation of hypoglycaemia
Thomas Høeg-Jensen, Thomas Kruse, Christian L. Brand, et al.
Nature (2024) Vol. 634, Iss. 8035, pp. 944-951
Open Access | Times Cited: 11
Oral peptide therapeutics for diabetes treatment: State-of-the-art and future perspectives
Bingwen Ding, Zhu Zhu, Cong Guo, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 5, pp. 2006-2025
Open Access | Times Cited: 10
Accelerating therapeutic protein design with computational approaches toward the clinical stage
Zhidong Chen, Xinpei Wang, Xu Chen, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 2909-2926
Open Access | Times Cited: 22
Targeted protein delivery based on stimuli‐triggered nanomedicine
Jinzhao Liu, Yang Zhou, Qingyang Lyu, et al.
Exploration (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 19
Effective GH Replacement With Somapacitan in Children With GHD: REAL4 2-year Results and After Switch From Daily GH
Bradley S. Miller, Joanne Blair, Michael Højby Rasmussen, et al.
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 108, Iss. 12, pp. 3090-3099
Open Access | Times Cited: 15
Uncovering CNS access of lipidated exendin-4 analogues by quantitative whole-brain 3D light sheet imaging
Grethe Skovbjerg, Urmas Roostalu, Casper G. Salinas, et al.
Neuropharmacology (2023) Vol. 238, pp. 109637-109637
Closed Access | Times Cited: 14
Impact of conjugation to different lipids on the lymphatic uptake and biodistribution of brush PEG polymers
Mohammad Abdallah, Lihuan Lin, Ian K. Styles, et al.
Journal of Controlled Release (2024) Vol. 369, pp. 146-162
Open Access | Times Cited: 5
Solid-Phase Synthesis as a Tool to Create Exactly Defined, Branched Polymer Vectors for Cell Membrane Targeting
Johanna K. Elter, Veronika Liščáková, Oliver Moravec, et al.
Macromolecules (2024) Vol. 57, Iss. 3, pp. 1050-1071
Open Access | Times Cited: 4
Forced Degradation Products of Liraglutide: A Comparative Study of Similarity Between Originator and Analogue Version by Liquid Chromatography–Mass Spectrometry
Fatemeh Chavoshi, Seyedeh Zohreh Mirjalili, Ali Mohammadi, et al.
International Journal of Peptide Research and Therapeutics (2024) Vol. 30, Iss. 3
Closed Access | Times Cited: 4
Fmoc Solid-Phase Peptide Synthesis
Per Brinch Hansen, Alberto Oddo
Methods in molecular biology (2024), pp. 33-55
Closed Access | Times Cited: 4
Fatty acid conjugated BimBH3 analogues with d‑amino acid substitution as PTPN1 inhibitors with enhanced activity, biostability and orally available potency for the treatment of diabetes
Liyan Gong, Dong Guo-zhen, Qianqian Zhang, et al.
Bioorganic & Medicinal Chemistry (2025) Vol. 121, pp. 118107-118107
Closed Access
Lipid metabolic reprograming: the unsung hero in breast cancer progression and tumor microenvironment
Mengting Wan, Shuaikang Pan, Benjie Shan, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Unveiling the Hidden: Dissecting Liraglutide Oligomerization Dual Pathways via Direct Mass Technology, Electron-Capture Dissociation, and Molecular Dynamics
Syuan‐Ting Kuo, Zhenyu Xi, Xiao Cong, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
2FA-Platform Generates Dual Fatty Acid-Conjugated GLP-1 Receptor Agonist TE-8105 with Enhanced Diabetes, Obesity, and NASH Efficacy Compared to Semaglutide
Melvin D.S. Wong, Pei‐Hsuan Lin, Wei‐Chen Lin, et al.
Journal of Medicinal Chemistry (2025)
Open Access
Rational Design of Site-Specific Fatty Acid Derivatives to Extend the Half-Life of Fibroblast Growth Factor 21
Chengcheng Wang, Yapeng Wang, Yuanzhen Dong, et al.
Bioconjugate Chemistry (2025)
Closed Access
Design of a novel long-acting insulin analogs by acetylation modification and compared with insulin Icodec
Min Yu, Chao Zhang, Hongjiang Xu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Variant screening of PYY 3–36 leads to potent long-acting PYY analogs with superior Y 2 receptor selectivity
Søren Østergaard, Carsten Jessen, Johan F. Paulsson, et al.
Science Translational Medicine (2025) Vol. 17, Iss. 791
Closed Access
Comparative Study on Covalent and Noncovalent Endogenous Albumin-Binding β-Glucuronidase-Activated SN38 Prodrugs for Antitumor Efficacy
Yingxin Lu, Xing Jiang, Biyu Yang, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Development of a Long-Acting Interleukin-11 Antagonist for the Treatment of Renal Fibrosis
Ningning Pang, Na Zhao, Chunmei An, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Iterative Optimization Yields Stapled Peptides with Superior Pharmacokinetics and Potency for Renal Fibrosis Treatment
Bochuan Deng, Ping Su, Cheng Lu, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Incretin-based therapeutics for the treatment of neurodegenerative diseases
Anika Vear, Michael T. Heneka, Christoffer Clemmensen
Nature Metabolism (2025)
Closed Access
Current progress and remaining challenges of peptide–drug conjugates (PDCs): next generation of antibody-drug conjugates (ADCs)?
Dongyuan Wang, Feng Yin, Zigang Li, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top